Similar articles

• Evidence for a local effect of intracervical prostaglandin E2-gel.

  Forman A, Ulmsten U, Bányai J, Wingerup L, Uldbjerg N. Forman A, et al. Am J Obstet Gynecol. 1982 Aug 1;143(7):756-60. doi: 10.1016/0002-9378(82)90005-9. Am J Obstet Gynecol. 1982. PMID: 6954849
• Effects of intracervical PGE2-gel on myometrial activity and cervical state in first trimester pregnancy.

  Forman A, Ulmsten U, Wingerup L, Bányai J. Forman A, et al. Prostaglandins. 1982 Sep;24(3):303-12. doi: 10.1016/0090-6980(82)90157-5. Prostaglandins. 1982. PMID: 6961477 Clinical Trial.
• A new prostaglandin E2-gel for pretreatment of the cervix in nulliparous patients having a late first trimester termination of pregnancy.

  Wingerup L, Ulmsten U, Bygdeman M, Ekman G, Hamberger L, Lundström V, Norström A. Wingerup L, et al. Arch Gynecol. 1981;231(1):1-6. doi: 10.1007/BF02110018. Arch Gynecol. 1981. PMID: 6949498
• Efficacy of an intracervical prostaglandin E2 preparation, Cerviprost, on cervical ripening before first trimester abortion in nulliparous patients.

  Irvine LM, Shaw RW. Irvine LM, et al. J Obstet Gynaecol (Lahore). 1989;10(2):120-3. doi: 10.3109/01443618909151126. J Obstet Gynaecol (Lahore). 1989. PMID: 12283723
• Cervical dilatation with pessaries containing a new prostaglandin E1 analogue in patients undergoing induced abortion.

  Nakano R. Nakano R. Am J Obstet Gynecol. 1982 Dec 1;144(7):862. doi: 10.1016/0002-9378(82)90372-6. Am J Obstet Gynecol. 1982. PMID: 7148915 No abstract available.